Publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018

2021Publications

Publications, 2021; Total of 24 Publications (20 peer reviewed journal articles, 5 book chapters)

(Bolded = CNUCOP faculty member, underlined/italics = CNUCOP student, italics = CNUCOP staff member)

1. Welly Mente, Ashim Malhotra, Erika Young, Nivas Brar, Bin Guan, Xiaodong Feng. 2021. Oncology biosimilars: Patient Access and Administration. Handbook of Biosimilars.
2. Kevin C. O'Connor, Xiaodong Feng, Brent Luu. Chapter 4: Pharmacogenetics and Pharmacogenomics. Advanced Pharmacology for Providers. Editors; Kauschinger, E., Venugopal, S., and Feng, X. 2021. Springer Publishing Company, New York, USA. 2021. ISBN: 978-0-8261-9546-3 (Print) 978-0-8261-9547-0 (eBook). DOI: 10.1891/9780826195470
3. Hongbin Wang, Peter Tenerelli, Simeon O. Kotchoni, Ahmed El-Shamy, Erika Young, Michael Casner, Catherine F. Yang. Chapter 7: Drug Development and Approval. Advanced Pharmacology for Providers. Editors; Kauschinger, E., Venugopal, S., and Feng, X. 2021. Springer Publishing Company, New York, USA. 2021. ISBN: 978-0-8261-9546-3 (Print) 978-0-8261-9547-0 (eBook). DOI: 10.1891/9780826195470
4. Thamer Khasawneh, Matthew Horton. Chapter 25: Pharmacotherapy for Hematologic Disorders. Advanced Pharmacology for Providers. Editors; Kauschinger, E., Venugopal, S., and Feng, X. 2021. Springer Publishing Company, New York, USA. 2021. ISBN: 978-0-8261-9546-3 (Print) 978-0-8261-9547-0 (eBook). DOI: 10.1891/9780826195470
5. Tianhong Li, Weijie Ma, and Xiaodong Feng. Chapter 26. Hematology/Oncology and Supportive Care for the Non-oncologist. Advanced Pharmacology for Providers. Editors; Kauschinger, E., Venugopal, S., and Feng, X. Springer Publishing Company, New York, USA. 2021. ISBN: 978-0-8261-9546-3 (Print) 978-0-8261-9547-0 (eBook). DOI: 10.1891/9780826195470
6. Erika N Titus-Lay, Heather A Jaynes, Elena Tomaselli Muensterman, Todd A Walroth, Carol A Ott, Zeruesenay Desta, Gabriela Williams, Paul R Moe, Michelle Wilbrandt, James E Tisdale. Methadone-Associated QT Interval Prolongation in Patients Undergoing Maintenance Therapy in an Urban Opioid Treatment Program. 2020. Pharmacotherapy. doi: 10.1002/phar.2498. Online ahead of print. https://pubmed.ncbi.nlm.nih.gov/33345336/
7. Ruth Vinall and Peter Balan. Use of Concept Mapping to Identify Expectations of Pharmacy Students Selecting Elective Courses. Pharmacy. 2021. Jan 8: 9(1): E14. doi: 10.3390/pharmacy9010014. https://pubmed.ncbi.nlm.nih.gov/33435603/
8. Oanh Ma, Truc Le, George Talbott, Tram Hoang Thao Nguyen, Dorothy Ha, Linh Ho. Sirt3 regulates adipogenesis and adipokine secretion via its enzymatic activity. 2021. Pharmacology Research & Perspectives. https://pubmed.ncbi.nlm.nih.gov/33191653/
9. Matteo Moretti, Ashim Malhotra, Silvia D. Visonà, Sheree J. Finley, Antonio Marco Maria Osculati, and Gulnaz T. Javan. The roles of medical examiners in the COVID-19 era: a comparison between the United States and Italy. Forensic Sci Med Pathol. 2021 Feb 13 : 1–9. https://pubmed.ncbi.nlm.nih.gov/33582936/
10. Nicholas M Smith, Alexa Ang, Fanny Tan, Katelyn Macias , Sarah James, Jasleen Sidhu, Justin R Lenhard. Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro β-lactam exposure. 2021. Antimicrobial Agents and Chemotherapy. doi:10.1128/AAC.02414-20. https://pubmed.ncbi.nlm.nih.gov/33495215/
11. Sprenger S, Woldemariam T, Chaturvedi LS. Induction of Adipogenic Genes by Novel Serum-Free Conditions From Pre-adipocyte 3T3-L1 and ST2 Cells. 2021. Cureus 13(3): e13831. doi:10.7759/cureus.13831. Cureus | Induction of Adipogenic Genes by Novel Serum-Free Conditions From Pre-adipocyte 3T3-L1 and ST2 Cells
12. Nicholas M Smith, Alexa Ang, Fanny Tan, Katelyn Macias , Sarah James, Jasleen Sidhu, Justin R Lenhard. Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro β-lactam exposure. 2021. Antimicrobial Agents and Chemotherapy. 2021. doi:10.1128/AAC.02414-20. https://pubmed.ncbi.nlm.nih.gov/33495215/
13. Rania Elkeeb, Tony Eid, Janie Yu, Hang Nguyen. Eman Atef. Can a monthly exenatide extended release regimen provide a therapeutic and cost benefit? Biopharmaceutics & Drug Disposition. 2021. doi: 10.1002/bdd.2279. https://pubmed.ncbi.nlm.nih.gov/33876430/
14. Erika N Titus-Lay, Heather A Jaynes, Elena Tomaselli Muensterman, Carol A Ott, Todd A Walroth, Gabriela Williams, Paul R Moe, Michelle Wilbrandt, James E Tisdale. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy. Pharmacotherapy. 2021. doi: 10.1002/phar.2521. https://pubmed.ncbi.nlm.nih.gov/33772822/
15. Taslim A Al-Hilal, Mohammad Anwar Hossain, Ahmad Alobaida, Farzana Alam, Ali Keshavarz, Eva Nozik-Grayck, Kurt R Stenmark, Nadezhda A German, Fakhrul Ahsan. Design, synthesis and biological evaluations of a long-acting, hypoxia-activated prodrug of fasudil, a ROCK inhibitor, to reduce its systemic side-effects. J Control Release. 2021. doi: 10.1016/j.jconrel.2021.04.030.https://pubmed.ncbi.nlm.nih.gov/33915222/
16. Hye T, Dwivedi P, Li W, Lahm T, Nozik ES, Stenmark KR, Ahsan F. New insights into the pathobiological and pharmacological basis of the sex-disparity in patients with pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2021. doi: 10.1152/ajplung.00559.2020. https://pubmed.ncbi.nlm.nih.gov/33719549/
17. Ashim Malhotra, Catherine Yang, Xiaodong Feng. Application of constructivism and cognitive flexibility theory to build a Comprehensive, Integrated, Multimodal Interprofessional Education and Practice (IPEP) program. J Interprof Care. 2021. DOI: 10.1080/13561820.2021.1900802. https://pubmed.ncbi.nlm.nih.gov/34003047/
18. Song Oh, Raymond Chau, Anh T Nguyen, Justin R Lenhard. Losing the Battle but Winning the War: Can Defeated Antibacterials Form Alliances to Combat Drug-Resistant Pathogens? 2021. Antibiotics 10(6):646. PMID: 34071451. DOI: 10.3390/antibiotics10060646. https://pubmed.ncbi.nlm.nih.gov/34071451/
19. Venkatachari Seshadri, Howard Maibach, and Tibebe Woldemariam. Role of Plant Extracts and Plant compounds for COVID-19 Intervention. 2021. Journal of Research in Pharmaceutical Science 7(6):4-13. ISSN(Online): 2347-2995. www.questjournals.org.
20. Ashim Malhotra, Indra K. Reddy, Michael Fulford, Fadi T. Khasawneh, Amit K. Tiwari, Xiaodong Feng. Strategies for the integration of foundational and clinical sciences in doctor of pharmacy programs. 2021. Journal of the American College of Clinical Pharmacy. DOI: 10.1002/jac5.1482. https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jac5.1482
21. Tiffany A McMurtry, Ayeh Barekat, Fantasia Rodriguez, Parwinder Purewal, Zackery P Bulman, Justin R Lenhard. Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure. 2021. J Antimicrob Chemother. DOI: 10.1093/jac/dkab211. https://pubmed.ncbi.nlm.nih.gov/34245262/
22. Hongbin Wang and Mengyao Liu. Complement C4, Infections, and Autoimmune Diseases. 2021. Front. Immunol. doi.org/10.3389/fimmu.2021.694928. https://www.frontiersin.org/articles/10.3389/fimmu.2021.694928/full
23. Abdulmajeed Albalawi, Alanoud Alharbi, Mawaddah Altaleb, Mohammed Almatrafi, Shuruq Alzahuf, Omayrah Alanzi, Aljawharh Alawad, Asayel Mohammed Bin Saif, Sarah Almuwarraee, Bader Alotaibi, Faisal Almishali, Tarek Kassem, Fatimah Alrajab, Omar Almatrafi, Hezam Alshahrani. Efficacy of Acetazolamide in management of idiopathic intracranial hypertension: A systematic review and meta-analysis. 2021. Medical Science. 25(114), 1827-1836.
24. Ashim Malhotra, Indra K. Reddy, Michael Fulford, Fadi T. Khasawneh, Amit K. Tiwari, Xiaodong Feng. Strategies for the integration of foundational and clinical sciences in doctor of pharmacy programs. 2021. Journal of the American College of Clinical Pharmacy. DOI: 10.1002/jac5.1482. https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1002/jac5.1482
25. Thomas Steele, Anhao Sam, Shawna Evans, Elizabeth Browning, Sheryl Krig, Katelyn Macias, Adarsh Konda, Salma Siddiqui, Blythe Durbin-Johnson, Paramita Ghosh, Ruth Vinall. Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes. Cancers. 2021. doi: 10.3390/cancers13174425. https://pubmed.ncbi.nlm.nih.gov/34503235/